Back

Discovery and verification of disulfidptosis-associated gene expression alterations in hypertrophic cardiomyopathy

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (4) - Molecular mechanisms and genetic insights in cardiomyopathies Cardiomyopathies ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Xin Tan

Suzhou (China)

9 More presentations in this session

Presentation thumbnail
Discussant - Molecular mechanisms and genetic insights in cardiomyopathies
Presentation thumbnail
Whole-exome sequencing generated polygenic risk score and risk stratification in Taiwanese genetic cardiomyopathies: a nation-wide sudden arrhythmia death syndrome (SADS) Taiwan registry
Doctor H. Tseng (Hsinchu, TW)
Abstract Slides Video
Presentation thumbnail
Alternative RNA splicing in genetic and ischemic dilated cardiomyopathy
Doctor Y. Devaux (Luxembourg, LU)
Abstract Slides Video
Presentation thumbnail
Comprehensive genetic analysis of desmoglein-2 in arrhythmogenic cardiomyopathy
Associate Professor K. Pilichou (Padova, IT)
Abstract
Presentation thumbnail
Next-generation cardiomyopathy models: CRISPR/Cas9-edited pigs for personalized cardiac therapeutics
Ms M. Arevalo (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (4) - Molecular mechanisms and genetic insights in cardiomyopathies

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Prediction of cardiac death in patients with hypertrophic cardiomyopathy using RNA-sequencing of plasma small non-coding RNAS
thumbnail
Congress Presentation
Unravelling the progression of hypertrophic cardiomyopathy: computational insights into MYH7 mutations, ionic remodelling, hypertrophy, and targeted therapy development
thumbnail
Congress Presentation
Genetic architecture of hypertrophic cardiomyopathy in individuals of Chinese and UK

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources